Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2525029rdf:typepubmed:Citationlld:pubmed
pubmed-article:2525029lifeskim:mentionsumls-concept:C0004334lld:lifeskim
pubmed-article:2525029lifeskim:mentionsumls-concept:C0162449lld:lifeskim
pubmed-article:2525029lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:2525029pubmed:issue3lld:pubmed
pubmed-article:2525029pubmed:dateCreated1989-7-3lld:pubmed
pubmed-article:2525029pubmed:abstractTextAurintricarboxylic acid (ATA) was found to be a very potent inhibitor of purified rabbit liver phosphofructokinase (PFK), giving 50% inhibition at 0.2 microM. The inhibition was in a manner consistent with interaction at the citrate-inhibitory site of the enzyme. The data suggest that inhibition of PFK by ATA was not due to denaturation of the enzyme or the irreversible binding of inhibitor, since the inhibition could be reversed by addition of allosteric activators of PFK, i.e. fructose 2,6-bisphosphate or AMP. Two other tricarboxylic acids, agaric acid and (-)-hydroxycitrate, were found to inhibit PFK. ATA at much higher concentrations (500 microM) was shown to inhibit fatty acid synthesis from endogenous glycogen in rat hepatocytes; however, protein synthesis was not altered.lld:pubmed
pubmed-article:2525029pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:languageenglld:pubmed
pubmed-article:2525029pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:citationSubsetIMlld:pubmed
pubmed-article:2525029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525029pubmed:statusMEDLINElld:pubmed
pubmed-article:2525029pubmed:monthMaylld:pubmed
pubmed-article:2525029pubmed:issn0264-6021lld:pubmed
pubmed-article:2525029pubmed:authorpubmed-author:McCuneS ASAlld:pubmed
pubmed-article:2525029pubmed:authorpubmed-author:KempR GRGlld:pubmed
pubmed-article:2525029pubmed:authorpubmed-author:FOXM SMSlld:pubmed
pubmed-article:2525029pubmed:authorpubmed-author:JurinR RRRlld:pubmed
pubmed-article:2525029pubmed:issnTypePrintlld:pubmed
pubmed-article:2525029pubmed:day1lld:pubmed
pubmed-article:2525029pubmed:volume259lld:pubmed
pubmed-article:2525029pubmed:ownerNLMlld:pubmed
pubmed-article:2525029pubmed:authorsCompleteYlld:pubmed
pubmed-article:2525029pubmed:pagination925-7lld:pubmed
pubmed-article:2525029pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:meshHeadingpubmed-meshheading:2525029-...lld:pubmed
pubmed-article:2525029pubmed:year1989lld:pubmed
pubmed-article:2525029pubmed:articleTitleAurintricarboxylic acid is a potent inhibitor of phosphofructokinase.lld:pubmed
pubmed-article:2525029pubmed:affiliationDepartment of Food Science and Nutrition, Ohio State University, Columbus 43210.lld:pubmed
pubmed-article:2525029pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2525029pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2525029pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2525029lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2525029lld:pubmed